Mylan Pharmaceuticals is recalling 3,816 bottles of Tacrolimus Capsules, USP 5mg (generic Prograf) because a single 1mg capsule may have been accidentally included in a bottle of 5mg capsules. Tacrolimus is an immunosuppressant used to prevent organ rejection in transplant patients, and taking the wrong strength could lead to under-dosing. These prescription capsules were distributed in 100-count bottles nationwide and were manufactured in the United States. If you have this medication, you should immediately check your bottle to ensure all capsules are the correct strength before your next dose.
If a patient accidentally takes a 1mg capsule instead of their prescribed 5mg dose, they will receive significantly less medication than required. This under-dosing can lead to a decrease in the drug's effectiveness in the body, potentially increasing the risk of organ transplant rejection.
Healthcare consultation and pharmacy return
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.